COMPANY

Sinaptica Therapeutics

Keywords: neuromodulation neurology Alzheimer's disease Alzheimer s Disease TMS-EEG

Location: Cambridge, MA · source · Oct 15, 2026

Profile checked Oct 10, 2026

Timeline

2026-10 Trial start —: Precuneus Mapping With Sinaptistim® (an Investigational TMS-EEG System) in Mild to Moderate AD Patients source ↗

2027-04 (ESTIMATED) · · Precuneus Mapping With Sinaptistim® (an Investigational TMS-EEG System) in Mild to Moderate AD Patients · NCT07841808

Estimated primary completion per ClinicalTrials.gov. Dates move.

Record	Title	Phase	Status	Start	Primary completion
NCT07841808	Precuneus Mapping With Sinaptistim® (an Investigational TMS-EEG System) in Mild to Moderate AD Patients	Not listed	Not yet recruiting	2026-10	2027-04 (estimated)